Saint Luke's Newsroom

KSHB talked to Dr. Lori Kramer about how many women are waiting to have children later in life.

HCP Live talked to Dr. Mikhail Kosiborod about the clinical impact of the DAPA-HF trial. 

Steve Lack, a patient at Saint Luke’s Liver Disease Management, talks to KSHB about his journey with NASH, why he participated in a clinical trial for NASH and still comes to Saint Luke's even though he moved nearly three hours away. 

Dr. Laura Alba, Medical Director of Hepatology, Saint Luke’s Liver Disease Management, talks to KCTV about what NASH is, how NASH affects patients, and why research for NASH is so important.

The trauma director at Saint Luke's Hospital of Kansas City, spoke with KSHB about the trauma team that mobilizes once an ambulance arrives, what has changed over the years in treating trauma victims, and why 'Stop the Bleed' is so important.

KSHB talked to Molly Pellettiere about how substance abuse in teens can impact brain development.

KSHB talked to Amanda Davis about the emotional impact of shootings and homicides on the community and how to help children process it all.

Medscape details the promising findings of the EXPLORER-HCM Phase 3 Trial presented by Dr. John Spertus at the 2021 ACC Scientific Session.

KSHB talked to Dr. Loethen about when she found herself in the Emergency Department after suffering a stroke.